Status:
COMPLETED
A Pilot Study of Probiotic Saccharomyces Boulardii Use in Chronic Heart Failure Patients. Estudo PROICA
Lead Sponsor:
Universidade Federal Fluminense
Conditions:
Heart Failure
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the feasibility, safety and effects in inflammatory response of the therapy with a probiotic agent, the yeast Saccharomyces boulardii (SB), in chronic heart fa...
Detailed Description
A cardiointestinal syndrome has been described in heart failure patients, with morphologic and functional intestinal disorders, increased enteropathogenic bacteria concentration, bacterial translocati...
Eligibility Criteria
Inclusion
- Class I or II (NYHA)heart failure patients
Exclusion
- Corticosteroid use within 30 days
- NSAID use within 30 days
- Antibiotic use within 30 days
- Acute infections
- Inflammatory diseases
- Autoimmune diseases
- Cancer
- Intestinal diseases
- Chronic renal failure
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01500343
Start Date
November 1 2008
End Date
December 1 2010
Last Update
December 28 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitário Antonio Pedro
Niterói, Rio de Janeiro, Brazil, 24033-900